The decision is expected to significantly reduce Bayer’s exposure to thousands of pending lawsuits tied to Roundup, the glyphosate-based herbicide originally developed by Monsanto, acquired by Bayer in 2018. The case arrived after litigation that included multibillion-dollar verdicts against the global agrochemical manufacturer.